Compare AVO & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVO | PAHC |
|---|---|---|
| Founded | 1983 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2020 | 2014 |
| Metric | AVO | PAHC |
|---|---|---|
| Price | $13.09 | $33.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | $17.00 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 1.5M | 277.6K |
| Earning Date | 06-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | 1.92 | ★ 1883.33 |
| EPS | N/A | ★ 1.90 |
| Revenue | ★ $1,391,200,000.00 | $833,350,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | $3.06 | $3.82 |
| P/E Ratio | ★ N/A | $17.31 |
| Revenue Growth | ★ 12.68 | 4.12 |
| 52 Week Low | $10.07 | $25.58 |
| 52 Week High | $15.53 | $60.08 |
| Indicator | AVO | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 59.93 | 53.70 |
| Support Level | $13.03 | $30.46 |
| Resistance Level | $14.28 | $34.57 |
| Average True Range (ATR) | 0.49 | 1.24 |
| MACD | 0.10 | 0.45 |
| Stochastic Oscillator | 67.99 | 78.78 |
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.